These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10899371)

  • 1. Naltrexone alteration of acute smoking response in nicotine-dependent subjects.
    King AC; Meyer PJ
    Pharmacol Biochem Behav; 2000 Jul; 66(3):563-72. PubMed ID: 10899371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and nicotine patch smoking cessation: a preliminary study.
    Krishnan-Sarin S; Meandzija B; O'Malley S
    Nicotine Tob Res; 2003 Dec; 5(6):851-7. PubMed ID: 14750508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
    Rukstalis M; Jepson C; Strasser A; Lynch KG; Perkins K; Patterson F; Lerman C
    Psychopharmacology (Berl); 2005 Jun; 180(1):41-8. PubMed ID: 15682300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.
    Hutchison KE; Monti PM; Rohsenow DJ; Swift RM; Colby SM; Gnys M; Niaura RS; Sirota AD
    Psychopharmacology (Berl); 1999 Feb; 142(2):139-43. PubMed ID: 10102765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.
    Weerts EM; Wand GS; Kuwabara H; Xu X; Frost JJ; Wong DF; McCaul ME
    Addict Biol; 2014 Jul; 19(4):733-42. PubMed ID: 23252742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of opioid antagonists for smoking cessation.
    David SP; Chu IM; Lancaster T; Stead LF; Evins AE; Prochaska JJ
    BMJ Open; 2014 Mar; 4(3):e004393. PubMed ID: 24633528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit.
    Toll BA; McKee SA; Martin DJ; Jatlow P; O'Malley SS
    Nicotine Tob Res; 2007 May; 9(5):597-605. PubMed ID: 17454716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS; Cooney JL; Krishnan-Sarin S; Dubin JA; McKee SA; Cooney NL; Blakeslee A; Meandzija B; Romano-Dahlgard D; Wu R; Makuch R; Jatlow P
    Arch Intern Med; 2006 Mar; 166(6):667-74. PubMed ID: 16567607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone attenuates acute cigarette smoking behavior.
    Epstein AM; King AC
    Pharmacol Biochem Behav; 2004 Jan; 77(1):29-37. PubMed ID: 14724039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women.
    King AC; Cao D; O'Malley SS; Kranzler HR; Cai X; deWit H; Matthews AK; Stachoviak RJ
    J Clin Psychopharmacol; 2012 Oct; 32(5):630-6. PubMed ID: 22926596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
    Knott VJ; Fisher DJ
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):368-81. PubMed ID: 17696684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antagonists for smoking cessation.
    David S; Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2001; (3):CD003086. PubMed ID: 11687036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine blood levels and subjective craving for cigarettes.
    Jarvik ME; Madsen DC; Olmstead RE; Iwamoto-Schaap PN; Elins JL; Benowitz NL
    Pharmacol Biochem Behav; 2000 Jul; 66(3):553-8. PubMed ID: 10899369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone augments the effects of nicotine replacement therapy in female smokers.
    Byars JA; Frost-Pineda K; Jacobs WS; Gold MS
    J Addict Dis; 2005; 24(2):49-60. PubMed ID: 15784523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone blockade of nicotine effects in cigarette smokers.
    Brauer LH; Behm FM; Westman EC; Patel P; Rose JE
    Psychopharmacology (Berl); 1999 Apr; 143(4):339-46. PubMed ID: 10367550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.
    McKee SA; Weinberger AH; Harrison EL; Coppola S; George TP
    Schizophr Res; 2009 Dec; 115(2-3):317-24. PubMed ID: 19700263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking and opioid detoxification: behavioral changes and response to treatment.
    Mannelli P; Wu LT; Peindl KS; Gorelick DA
    Nicotine Tob Res; 2013 Oct; 15(10):1705-13. PubMed ID: 23572466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.